Detalles de la búsqueda
1.
Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials.
Diabetes Obes Metab
; 18(10): 1045-9, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27265507
2.
Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings.
BMC Infect Dis
; 16(1): 764, 2016 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27993132
3.
SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases.
JAMA
; 325(15): 1561-1562, 2021 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33605978
4.
Detection of resistance to macrolides and fluoroquinolones in Mycoplasma genitalium by targeted next-generation sequencing.
Microbiol Spectr
; : e0384523, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349187
5.
Impact of the 2014 CDC HIV testing guidelines on detection of acute HIV infections.
J Clin Virol
; 146: 105058, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973475
6.
Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study.
Dermatol Ther (Heidelb)
; 12(2): 511-527, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038128
7.
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study.
Exp Hematol Oncol
; 9: 20, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32793403
8.
Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study.
World Allergy Organ J
; 13(4): 100117, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32382379
9.
Comparative Performance of the Reverse Algorithm Using Architect Syphilis TP Versus the Traditional Algorithm Using Rapid Plasma Reagin in Florida's Public Health Testing Population.
Ann Lab Med
; 39(4): 396-399, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30809986
10.
Partnerships Involved in Public Health Testing for Zika Virus in Florida, 2016.
Public Health Rep
; 134(2_suppl): 43S-52S, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31682557
11.
Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
J Clin Virol
; 91: 79-83, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434810
12.
Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes.
J Diabetes Investig
; 7(5): 744-50, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27180969
13.
Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials.
J Diabetes Complications
; 30(8): 1622-1630, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27499458
14.
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.
Diab Vasc Dis Res
; 13(2): 119-26, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26873905
15.
Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials.
J Diabetes Complications
; 30(8): 1571-1576, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27499456
16.
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.
Diabetes Care
; 38(9): 1730-5, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26180105
17.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials.
Postgrad Med
; 127(5): 419-28, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840727
18.
Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.
Diab Vasc Dis Res
; 12(4): 249-57, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25941160
19.
Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.
Clin Ther
; 36(8): 1130-46, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25015594
20.
Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
J Clin Virol
; 58 Suppl 1: e29-33, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24342476